A detailed history of Capital Square, LLC transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Capital Square, LLC holds 20,600 shares of ORGO stock, worth $62,829. This represents 0.04% of its overall portfolio holdings.

Number of Shares
20,600
Previous 20,300 1.48%
Holding current value
$62,829
Previous $56,000 3.57%
% of portfolio
0.04%
Previous 0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$2.42 - $3.24 $726 - $972
300 Added 1.48%
20,600 $58,000
Q2 2024

Aug 01, 2024

BUY
$2.28 - $3.03 $113 - $151
50 Added 0.25%
20,300 $56,000
Q1 2024

May 07, 2024

SELL
$2.61 - $4.49 $522 - $898
-200 Reduced 0.98%
20,250 $57,000
Q4 2023

Jan 26, 2024

BUY
$1.97 - $4.21 $7,742 - $16,545
3,930 Added 23.79%
20,450 $83,000
Q3 2023

Nov 09, 2023

BUY
$2.34 - $4.43 $38,656 - $73,183
16,520 New
16,520 $52,000

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $399M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Capital Square, LLC Portfolio

Follow Capital Square, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Square, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Square, LLC with notifications on news.